HAWK and HARRIER

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

Medicine, Ophthalmology, Surgery +12

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel, Adrian Koh, Yuichiro Ogura et al. · Ophthalmology · 2019 · 911 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

Ursula Schmidt‐Erfurth, Peter K. Kaiser, Jean‐François Korobelnik et al. · Ophthalmology · 2013 · 811 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

Maureen G. Maguire, Daniel Martín, Gui‐Shuang Ying et al. · Ophthalmology · 2016 · 705 citations · Full text

Medicine, Ophthalmology, Surgery +12

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

Frank G. Holz, Ramin Tadayoni, Stephen Beatty et al. · British Journal of Ophthalmology · 2014 · 613 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17